Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
11
×
boston blog main
clinical trials
11
×
deals
11
×
life sciences
national blog main
boston top stories
fda
investing
san francisco blog main
national top stories
alexion pharmaceuticals
eli lilly
roche
san francisco top stories
startups
autoimmune disorders
boehringer ingelheim
drug delivery
hepatitis b
indiana blog main
medical device
rna interference
venture capital
480 biomedical
abbvie
akouos
allergan
allosteric
alnylam pharmaceutials
alnylam pharmaceuticals
alzheimer's disease
amyotrophic lateral sclerosis (als)
arrowhead pharmaceuticals
arrowmark partners
arsenal medical
astellas pharmaceuticals
atlas venture
atopic dermatitis
What
medicines
drug
therapeutics
developing
disease
million
pharma
treat
ago
biotech
candidate
company
deal
dicerna
fda
gene
ipo
new
pact
patients
pharmaceuticals
potential
raised
research
roche
startup
team
tests
abandoning
abbvie
address
adds
affects
alliance
allosteric
alternative
americans
analytics
approval
approved
Language
unset
Current search:
deals
×
boston
×
" clinical trials "
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Synlogic Lands $80M from Ginkgo to Ramp Up “Living Medicines” R&D
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M